Online citations, reference lists, and bibliographies.
← Back to Search

Blefarospasmo Essencial E Espasmo Hemifacial: Características Dos Pacientes, Tratamento Com Toxina Botulínica A E Revisão Da Literatura

S. Schellini, Olívia Matai, T. Z. Igami, C. Padovani, C. Padovani
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
PURPOSE: To evaluate the characteristics of the essential blepharospasm and hemifacial spasm patients and the feasible treatment with botulinum toxin A. METHODS: Thirty-four essential blepharospasm or hemifacial spasm patients were evaluated according to gender, ocular complaint, time of disease, treatment outcome and complications. RESULTS: Age median was 63 years and the mean was 61 years, with no difference regarding sex; 66.66% of the patients had hemifacial spasm and 33.33%, essential blepharospasm. Many patients complained of dry eye associated with involuntary spasm. Botulinum toxin A showed a positive outcome in 91.30% of the treated patients and complications observed after treatment were eyelid ptosis (8.33%) and buccal angle deviation (8.33%). CONCLUSION: Essential blepharospasm and hemifacial spasm occurred in the elderly, of both sexes. Treatment with botulinum toxin A was useful, with very low complication rates.
This paper references
Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
A. Thussu (1999)
[Indications and management of botulinum toxin].
C. Singer (1999)
Quality of life in patients with blepharospasm
O. Tucha (2001)
Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
J. Mauriello (1996)
Treatment of blepharospasm with botulinum toxin.
E. A. Tsoy (1985)
[Applications of the botulinum A toxin].
Magdolna Zajácz (2003)
The significance of ophthalmological symptoms in idiopathic blepharospasm
J. S. Elsron (1988)
Experiência com aplicação de toxina botulínica A em 115 pacientes
L. A. Andrade (1997)
Botulinum toxin A injection in the treatment of hemifacial spasm
R. S. Chen (1996)
Riolan's muscle: Action and indications for botulinum toxin injection
I. Mackie (2000)
Blepharospasm: Past, Present, and Future
R. Anderson (1998)
Indications and Limitations for the Use of Botulinum Toxin for the Treatment of Facial Wrinkles
M. Sarrabayrouse (2002)
A novel mechanism for benign essential blepharospasm.
J. McCann (1999)
Botulism in the United States: A Clinical and Epidemiologic Review
R. Shapiro (1998)
Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins.
E. Johnson (1999)
[Current indications for the treatment with botulin toxin].
A. Kohler (2001)
Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.
J. Jankovic (1996)
Treatment of Blepharospasm with Botulinum Neurotoxin Type A: Long-Term Results
P. Calace (2003)
[Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
J. Wang (1998)
Botulinum A toxin injection as a treatment for blepharospasm.
A. Scott (1985)
Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm
R. Çakmur (2002)
Botulinum A Toxin: Dysport Improvement of Biological Availability
H. Bigalke (2001)
Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm.
G. Cibis (1985)
Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches.
M. Faulstich (1985)
Benign Essential Blepharospasm Among Residents of Olmsted County, Minnesota, 1976 to 1995: An Epidemiologic Study
E. Bradley (2003)
Tratamento do espasmo facial unilateral com toxina botulínica tipo A
M. D. C. Cunha (1998)
Treatment of Hyperfunctional Lines of the Face with Botulinum Toxin A
W. Binder (1998)
Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
L. Chang (1999)
Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases.
H. Levin (2000)
Pretarsal application of botulinum toxin for treatment of blepharospasm.
M. Aramideh (1995)
[Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
P. Schnider (1999)
DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1
C. Sampaio (1997)
The use of botulinum toxin in blepharospasm.
N. Shorr (1985)
[Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
F. Cardoso (2003)
Treatment of blepharospasm with botulinum toxin. A preliminary report.
B. Frueh (1984)
Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye
J. Horwath-Winter (2003)
Blepharospasm: a review of 264 patients.
F. Grandas (1988)
Hemifacial spasm and involuntary facial movements.
N. Tan (2002)
Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm.
A. Broocks (1998)

This paper is referenced by
Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
E. Barbosa (2010)
Análise da ceratometria corneana em pacientes portadores de espasmo hemifacial
Ivana Cardoso Pereira (2011)
Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated.
Jean Pierre Mette Batisti (2017)
Aberrações ópticas de alta ordem em pacientes com distonias faciais tratados com toxina botulínica
Mariann Midori Yabiku (2011)
Efeitos adversos associados à aplicação de toxina botulínica na face: revisão sistemática com meta-análise
R. Zagui (2008)
[Adverse effects associated with facial application of botulinum toxin: a systematic review with meta-analysis].
R. Zagui (2008)
Resultados tardios da descompressão microvascular do nervo facial pela artéria vertebral Long-term Outcomes of Facial Nerve Microvascular Decompression by Vertebral Artery
José Nazareno (2012)
[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].
Mariann Midori Yabiku (2011)
[Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
Fernanda Castro de Oliveira (2010)
A utilização da toxina botulínica tipo a para alcançar a estética facial
D. M. Barbosa (2020)
Essential Blepharospasm and Hemifacial Spasm
Ilya M. Leyngold (2012)
Custos e eficácia da toxina botulínica tipo A no tratamento do blefaroespasmo essencial e espasmo hemifacial
Cintia Gomes Galvão Lasalvia (2006)
Semantic Scholar Logo Some data provided by SemanticScholar